Incidence of group B strep has decreased among newborns, but has increased among adults

Group B streptococcus, a major cause of serious infections, declined about 25 percent among infants younger than 7 days from 1999 to 2005, but increased nearly 50 percent among persons 15 to 64 years old, according to a study in the May 7 issue of JAMA.

In the 1970s, group B streptococcus emerged as the leading cause of sepsis and meningitis in the first week of life. Subsequent prevention strategies resulted in substantial declines in disease in infants younger than 7 days (also known as early-onset disease). Guidelines for prevention of this disease near the time of birth were revised in 2002. Disease trends following the release of these guidelines have not yet been well studied.

In addition to illness in the first week of life, group B streptococcus also causes invasive disease in older infants, pregnant women, children and young adults with underlying medical conditions and older adults. “The epidemiology of group B streptococcal disease is dynamic, and continued surveillance to monitor trends across age groups is necessary. For example, an increase in disease incidence among nonpregnant adults has been documented in past decades, but whether that trend has continued is unknown,” the authors write. In the United States in 2005, group B streptococcus caused an estimated 21,500 cases of invasive disease and 1,700 deaths, according to information in the article.

Christina R. Phares, Ph.D., of the Centers for Disease Control and Prevention, Atlanta, and colleagues evaluated trends and characteristics over a recent period among cases of laboratory-confirmed invasive group B streptococcal disease identified by population-based surveillance in 10 states participating in the Active Bacterial Core surveillance/Emerging Infections Program Network.

From 1999 through 2005, surveillance identified 14,573 cases of invasive group B streptococcal disease, of which 1,232 were early-onset disease. Disease incidence decreased 27 percent after the 2002 release of revised early onset disease prevention guidelines, from 0.47 per 1,000 live births in 1999-2001 to 0.34 per 1,000 live births in 2003-2005. Incidence remained stable among infants age 7 to 89 days and pregnant women.

Group B strep incidence increased 48 percent for those age 15 to 64 years, while those 65 years or older experienced a 20 percent increase. Among persons age 15 through 64 years, incidence increased from 3.4 per 100,000 population in 1999 to 5.0 per 100,000 in 2005; among those 65 years or older, incidence increased from 21.5 per 100,000 to 26.0 per 100,000. These values translate to a 32 percent increase in the overall incidence of adult disease, which reached 7.9 per 100,000 in 2005. The proportion with known outcome who died was highest in the oldest age groups.

All 4,882 isolates tested were susceptible to the antibiotics penicillin, ampicillin, and vancomycin, but 32 percent and 15 percent were resistant to erythromycin and clindamycin, respectively.

“… maternal group B streptococcus vaccination trials should be a public health priority, followed by expanded vaccine development to target disease among elderly and younger adults with chronic underlying conditions,” the authors conclude.

Source: JAMA and Archives Journals

Related stories:

New vaccines may not reduce TB incidence
(PhysOrg.com) -- Despite the potential of new vaccines to prevent TB, new research shows that the removal of one strain of TB can allow a previously suppressed strain to succeed. Consequently, a vaccination program could result in the proliferation of strains more likely to be, or become, drug resistant, and could even result in an increased prevalence of the disease.
Despite vaccine, public should not get complacent about pneumococcal disease
Although the childhood pneumococcal conjugate vaccine has been a boon in reducing the incidence invasive pneumococcal disease (IPD), the public and the medical community must not get complacent, as non-vaccine strains, some resistant to antibiotics, are on the rise, say scientists at a meeting today in Boston.
Pneumococcal disease rates down significantly post-vaccine
Since the approval of a vaccine against pneumococcal bacteria for young children in 2000, rates of invasive pneumococcal disease (IPD) are down significantly in all age groups, while rates of IPD caused by non-vaccine strains are modestly on the rise. Researchers from the Centers for Disease Control and Prevention (CDC) report their results today (March 18) at the 2008 International Conference on Emerging Infectious Diseases in Atlanta, Georgia.
Disease can be our ally, not just our enemy, says evolutionary biologist
In a time when we worry about bird flu and contaminated spinach, Marlene Zuk, an evolutionary biologist at UC Riverside, offers a fresh perspective on disease and the role it plays in our lives. Her new book, Riddled with Life: Friendly Worms, Ladybug Sex, and the Parasites that Make Us Who We Are (Harcourt, 2007), argues that disease is not always our foe; it can be a vital partner and friend.
Study finds stroke-prevention surgery safe in growing 80-plus population
New research published in the October issue of Journal of the American College of Surgeons challenges the current opinion that patients in their eighties, who are often deemed "high-risk" due to their advanced age, should not undergo carotid endarterectomy – a stroke-preventing surgical procedure that clears blockages from the neck's carotid arteries.
Waterborne disease risk upped in Great Lakes
An anticipated increased incidence of climate-related extreme rainfall events in the Great Lakes region may raise the public health risk for the 40 million people who depend on the lakes for their drinking water, according to a new study.
Researchers study prevention of blood clots in cancer patients
As more individuals with cancer are being treated as outpatients, the University of Rochester Medical Center is working on an emerging problem: how to prevent the life-threatening blood clots that can accompany some newer cancer drugs.
Medical data 'Internet' goes live, boosts research
Medical and life scientists will be able to share information collected from many thousands of cases thanks to a digital network being launched at The Australian National University in Canberra today.

News discussion:

Medicine & Health news